[go: up one dir, main page]

NO20053959D0 - Medikament omfattende hoy-aktiv langtidsvarende beta-2-abonist i kombinasjon med andre aktive bestanddeler - Google Patents

Medikament omfattende hoy-aktiv langtidsvarende beta-2-abonist i kombinasjon med andre aktive bestanddeler

Info

Publication number
NO20053959D0
NO20053959D0 NO20053959A NO20053959A NO20053959D0 NO 20053959 D0 NO20053959 D0 NO 20053959D0 NO 20053959 A NO20053959 A NO 20053959A NO 20053959 A NO20053959 A NO 20053959A NO 20053959 D0 NO20053959 D0 NO 20053959D0
Authority
NO
Norway
Prior art keywords
active
medication
subscriber
combination
long
Prior art date
Application number
NO20053959A
Other languages
English (en)
Other versions
NO20053959L (no
Inventor
Roberta Razzetti
Fiorella Pastore
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32748803&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20053959(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO20053959D0 publication Critical patent/NO20053959D0/no
Publication of NO20053959L publication Critical patent/NO20053959L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20053959A 2003-02-27 2005-08-25 Medikament omfattende hoy-aktiv langtidsvarende beta-2-aqonist i kombinasjon med andre aktive bestanddeler NO20053959L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03004184A EP1452179A1 (en) 2003-02-27 2003-02-27 Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid
PCT/EP2004/001960 WO2004075896A1 (en) 2003-02-27 2004-02-27 Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients

Publications (2)

Publication Number Publication Date
NO20053959D0 true NO20053959D0 (no) 2005-08-25
NO20053959L NO20053959L (no) 2005-11-28

Family

ID=32748803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053959A NO20053959L (no) 2003-02-27 2005-08-25 Medikament omfattende hoy-aktiv langtidsvarende beta-2-aqonist i kombinasjon med andre aktive bestanddeler

Country Status (32)

Country Link
US (1) US20070020190A1 (no)
EP (3) EP1452179A1 (no)
JP (1) JP2006519204A (no)
KR (1) KR20050104367A (no)
CN (2) CN100370986C (no)
AR (1) AR043419A1 (no)
AT (1) ATE401887T1 (no)
AU (1) AU2004216472B2 (no)
BR (1) BRPI0408047A (no)
CA (1) CA2517321A1 (no)
CY (1) CY1108360T1 (no)
DE (1) DE602004015260D1 (no)
DK (1) DK1603565T3 (no)
EA (1) EA008828B1 (no)
ES (1) ES2309503T3 (no)
HK (1) HK1087009A1 (no)
HR (1) HRP20050726A2 (no)
MA (1) MA27630A1 (no)
ME (1) MEP32208A (no)
MX (1) MXPA05009007A (no)
NO (1) NO20053959L (no)
NZ (1) NZ541997A (no)
PE (1) PE20050290A1 (no)
PL (1) PL377814A1 (no)
PT (1) PT1603565E (no)
RS (1) RS20050615A (no)
SA (1) SA04250122B1 (no)
SI (1) SI1603565T1 (no)
TN (1) TNSN05186A1 (no)
UA (1) UA82217C2 (no)
WO (1) WO2004075896A1 (no)
ZA (1) ZA200506820B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
EP1651224B1 (en) * 2003-07-31 2011-10-05 Boehringer Ingelheim International GmbH Medicaments for inhalation comprising an anticholinergic and a betamimetic
JP2007501194A (ja) * 2003-08-05 2007-01-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ステロイドとβ模倣薬を含む吸入用薬剤
CA2538419C (en) * 2003-09-16 2012-07-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
ES2570332T3 (es) * 2005-03-16 2016-05-17 Meda Pharma Gmbh & Co Kg La combinación de anticolinérgicos y antagonistas del receptor de leucotrieno para el tratamiento de enfermedades respiratorias
WO2006105401A2 (en) * 2005-03-30 2006-10-05 Schering Corporation Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist
EA013351B1 (ru) * 2005-08-01 2010-04-30 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Фармацевтические препараты, содержащие бета-агонист длительного действия, для введения путем распыления
ATE529399T1 (de) * 2005-11-10 2011-11-15 Nicholas S Bodor Sanfte anticholinerge ester
CA2824075C (en) * 2005-12-21 2015-04-28 Joachim Maus Combination of r, r-glycopyrrolate, formoterol, and a glucocorticoid for the treatment of inflammatory diseases
EP2029127A1 (en) * 2006-05-24 2009-03-04 Boehringer Ingelheim International GmbH New long-acting drug combinations for the treatment of respiratory diseases
EP1953143A1 (en) * 2007-01-30 2008-08-06 CHIESI FARMACEUTICI S.p.A. Process for the preparation of 8-hydroxy-5-[(1R)-1-hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloride
WO2008102128A2 (en) * 2007-02-19 2008-08-28 Cipla Limited Pharmaceutical combinations of at least two bronchodilators or of a bronchodilator with a corticosteroid
ES2394589T3 (es) 2007-12-14 2013-02-04 Aerodesigns, Inc Suministro de productos alimenticios transformables en aerosol
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2309858A4 (en) * 2008-07-31 2011-09-14 Dekel Pharmaceuticals Ltd COMPOSITIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES
WO2010097188A1 (en) * 2009-02-25 2010-09-02 Chiesi Farmaceutici S.P.A. Inhalation particles comprising a salt of carmoterol and a corticosteroid
AU2010252354B2 (en) * 2009-05-25 2016-05-19 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and a steroid
AU2015201037C1 (en) * 2009-05-29 2017-07-27 Pearl Therapeutics, Inc. Respiratory delivery of active agents
WO2010138884A2 (en) 2009-05-29 2010-12-02 Pearl Therapeutics, Inc. Compositions, methods & systems for respiratory delivery of two or more active agents
WO2011136753A1 (en) * 2010-04-26 2011-11-03 Mahmut Bilgic Combination of carmoterol and fluticasone for use in the treatment respiratory diseases
CN102247597B (zh) * 2010-05-19 2015-01-07 天津金耀集团有限公司 一种糖皮质激素与支气管扩张剂的吸入剂
WO2012007729A2 (en) * 2010-07-16 2012-01-19 Cipla Limited Pharmaceutical compositions
WO2012010854A1 (en) 2010-07-23 2012-01-26 Cipla Limited Inhalation formulations comprising carmoterol in combination with a corticosteroid
CN102416179B (zh) * 2010-09-28 2014-05-07 益得生物科技股份有限公司 用于哮喘的吸入性复方组合物
TWI399202B (zh) * 2011-03-17 2013-06-21 Intech Biopharm Ltd 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
KR102177982B1 (ko) * 2013-03-15 2020-11-13 베로나 파마 피엘씨 약물 복합제
EP3193862B1 (en) 2014-09-16 2023-10-18 Igc Pharma Ip, Llc Topical cannabinoid composition for treating arthritic pain
ES2895850T3 (es) * 2014-11-24 2022-02-22 Univ Illinois Procedimiento de prevención o tratamiento de una enfermedad o afección pulmonar
US10751300B2 (en) 2015-01-25 2020-08-25 India Globalization Capital, Inc. Composition and method for treating seizure disorders
WO2017027651A1 (en) * 2015-08-12 2017-02-16 India Globalization Capital, Inc. Method and composition for treating cachexia and eating disorders
EP3471746A4 (en) 2016-06-15 2020-02-26 India Globalization Capital, Inc. METHOD AND COMPOSITION FOR TREATING EPILEPTIC DISORDERS
CN115337311B (zh) * 2022-09-26 2023-05-09 南京恒道医药科技股份有限公司 一种治疗呼吸系统疾病的组合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
AU741783B2 (en) * 1997-03-20 2001-12-06 Merck Sharp & Dohme Corp. Preparation of powder agglomerates
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US20020081266A1 (en) * 1999-08-20 2002-06-27 Norton Healthcare Ltd. Spray dried powders for pulmonary or nasal administration
PE20011227A1 (es) * 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
CZ303833B6 (cs) * 2000-05-22 2013-05-22 Chiesi Farmaceutici S.P.A. Aerosolový prostredek
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
HUE049426T2 (hu) * 2002-03-01 2020-09-28 Chiesi Farm Spa Szuperfinom formoterolkészítmény
EP1595531A1 (en) * 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers

Also Published As

Publication number Publication date
TNSN05186A1 (en) 2007-06-11
HRP20050726A2 (en) 2006-02-28
NO20053959L (no) 2005-11-28
EP1603565A1 (en) 2005-12-14
DK1603565T3 (da) 2008-11-10
EP1834643A2 (en) 2007-09-19
DE602004015260D1 (de) 2008-09-04
MEP32208A (en) 2010-10-10
PL377814A1 (pl) 2006-02-20
AU2004216472A1 (en) 2004-09-10
UA82217C2 (uk) 2008-03-25
MXPA05009007A (es) 2005-10-18
CN101244063A (zh) 2008-08-20
ES2309503T3 (es) 2008-12-16
KR20050104367A (ko) 2005-11-02
MA27630A1 (fr) 2005-11-01
CN1753678A (zh) 2006-03-29
SI1603565T1 (sl) 2008-10-31
US20070020190A1 (en) 2007-01-25
ZA200506820B (en) 2006-11-29
RS20050615A (en) 2007-09-21
CA2517321A1 (en) 2004-09-10
BRPI0408047A (pt) 2006-02-14
PT1603565E (pt) 2008-10-06
EA200501108A1 (ru) 2006-04-28
NZ541997A (en) 2008-12-24
EP1834643A3 (en) 2007-10-24
HK1087009A1 (en) 2006-10-06
PE20050290A1 (es) 2005-05-26
EA008828B1 (ru) 2007-08-31
JP2006519204A (ja) 2006-08-24
AR043419A1 (es) 2005-07-27
SA04250122B1 (ar) 2009-03-11
EP1452179A1 (en) 2004-09-01
WO2004075896A1 (en) 2004-09-10
CY1108360T1 (el) 2014-02-12
AU2004216472B2 (en) 2009-08-06
CN100370986C (zh) 2008-02-27
EP1603565B1 (en) 2008-07-23
ATE401887T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
NO20053959D0 (no) Medikament omfattende hoy-aktiv langtidsvarende beta-2-abonist i kombinasjon med andre aktive bestanddeler
ZA200600099B (en) Active agents combination exhibiting insecticidal and acaricide properties
ATE300325T1 (de) Nadelloser injektor in miniaturausführung
IL175074A0 (en) Methods of using and compositions comprising selective cytokine inhibitory drugs for treatement, modification and management of pain
TW200716628A (en) Novel compounds
FR2866884B1 (fr) Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application en therapeutique
FR2873691B1 (fr) Derives d'amino-piperidine, leur preparation et leur application en therapeutique
FR2850377B1 (fr) Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
DE60142913D1 (de) Arzneilösungen enthaltend modafinilverbindungen
ATE356143T1 (de) Antibiotikum 107891, dessen faktoren a1 und a2, pharmazeutisch unbedenkliche salze und zusammensetzungen, und anwendung davon
FR2873690B1 (fr) Derives d'oxopiperidine, leur preparation et leur application en therapeutique
WO2005034857A8 (en) Methods and compositions comprising diamines as new anti-tubercular therapeutics
DE602004014787D1 (de) Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln
EP1731609A4 (en) INHIBITOR OF THE EXPRESSION OF RAD51, MEDICAMENT CONTAINING THE INHIBITOR AS ACTIVE INGREDIENT AND USE THEREOF
FR2873693B1 (fr) Derives d'amino-tropane, leur preparation et leur application en therapeutique
ZA200600098B (en) Active agents combination exhibiting insecticidal and acaricide properties
ITMI20030972A1 (it) Indazolo dotato di attivita' analgesica, metodo per prepararlo e composizione farmaceutica che lo comprende.
FR2850380B1 (fr) Derives d'acylaminothiazole, leur preparation et leur utilisation en therapeutique
DE60323138D1 (de) Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
NL1027109A1 (nl) Verbinding en gebruik bij behandeling.
EA200500175A1 (ru) Соль морфин-6-глюкуронида
ITMI20051417A1 (it) Formulazione topica in forma di gel contenente come ingredienti attivi ciclovit e lidocaina
ATE398462T1 (de) Impfverfahren gegen testikuläre bvdv-infektion
EP1591123A4 (en) USE OF NARINGENINE, NARINGIN AND THEIR SALTS AS EXPERTS IN THE TREATMENT OF COUGH AND COMPOSITIONS THEREOF
FR2866886B1 (fr) Derives d'aryl-et d'heteroaryl-akylcarbamates, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application